BIOREPOSITORY & TISSUE ANALYSIS

最初的霍林斯癌症中心（HCC）大楼是门诊癌症服务和研究的所在地，于1993年完工。仅仅十多年后，由于迫切需要扩大临床和研究活动的足迹，MUSC获得了9800万美元，用于增加一座七层楼的塔楼，并对原有的HCC大楼进行了重大翻新。这些项目已于2007年完成。在最初的癌症中心支持拨款（CCSG）项目期间（2009年至今），HCC领导层继续确保可用的设施符合HCC的战略计划，以发展其实验室，临床和癌症控制研究项目。领导层与MUSC管理部门以及建筑和工程团队密切合作，设计了额外的最先进的设施和空间。这导致了2011年底药物发现大楼（DDB）和生物工程大楼（BEB）的建设，投资1.2亿美元。HCC在这两栋新建筑中分配了大约三层半的楼层。如表1所示，hcc控制的总空间增加到270,174总英尺/桶，比最初提交的CCSG增加了33%。

The original Hollings Cancer Center (HCC) Building, home to outpatient cancer services and research, was completed in 1993. Just over a decade later due to the pressing need to expand the footprint for clinical and research activities, MUSC secured $98M to add a seven-story tower and significantly renovate the original HCC Building. These projects were completed in 2007. During the initial Cancer Center Support Grant (CCSG) project period (2009-present), the HCC leadership has continued to ensure that the available facilities match the HCC's strategic plans to grow its laboratory, clinical, and cancer control-based research programs. The leadership has worked closely with the MUSC administration and architectural and engineering teams to design additional state-of-the-art facilities and space. This has led to the construction of the Drug Discovery Building (DDB) and Bioengineering Building (BEB) in late 2011, a $120M investment. The HCC has assignment of approximately three and a half floors within these two new buildings. As shown in Table 1, the total HCC-controlled space has increased to 270,174 gross ft[2], a 33% increase since the initial CCSG submission.